Published in J Clin Virol on August 01, 2002
Detection of respiratory viruses by molecular methods. Clin Microbiol Rev (2008) 3.03
Detection of all known parechoviruses by real-time PCR. J Clin Microbiol (2008) 1.61
Genomic characterization of novel human parechovirus type. Emerg Infect Dis (2009) 1.37
Prevalence of human parechovirus in the Netherlands in 2000 to 2007. J Clin Microbiol (2008) 1.09
Diversity of human parechoviruses isolated from stool samples collected from Thai children with acute gastroenteritis. J Clin Microbiol (2009) 0.91
Changes in human parechovirus profiles in hospitalized children with acute gastroenteritis after a three-year interval in Lanzhou, China. PLoS One (2013) 0.85
Human parechovirus genotypes -10, -13 and -15 in Pakistani children with acute dehydrating gastroenteritis. PLoS One (2013) 0.79
Identification and characterization of unrecognized viruses in stool samples of non-polio acute flaccid paralysis children by simplified VIDISCA. Virol J (2014) 0.77
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg Infect Dis (2009) 3.76
High-resolution measurements of face-to-face contact patterns in a primary school. PLoS One (2011) 2.65
Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors. J Clin Virol (2007) 1.86
Sequencing of 'untypable' enteroviruses reveals two new types, EV-77 and EV-78, within human enterovirus type B and substitutions in the BC loop of the VP1 protein for known types. J Gen Virol (2003) 1.78
Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. J Clin Virol (2007) 1.67
The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis. Pediatr Infect Dis J (2008) 1.65
A supramolecular assembly formed by influenza A virus genomic RNA segments. Nucleic Acids Res (2011) 1.65
Mixed respiratory virus infections. J Clin Virol (2008) 1.46
High risk HPV contamination of endocavity vaginal ultrasound probes: an underestimated route of nosocomial infection? PLoS One (2012) 1.35
Risk of influenza-like illness in an acute health care setting during community influenza epidemics in 2004-2005, 2005-2006, and 2006-2007: a prospective study. Arch Intern Med (2011) 1.33
Epidemiology of human enterovirus 71 infections in France, 2000-2009. J Clin Virol (2010) 1.27
New enteroviruses, EV-93 and EV-94, associated with acute flaccid paralysis in the Democratic Republic of the Congo. J Med Virol (2007) 1.26
Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med (2010) 1.24
Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012. Emerg Infect Dis (2013) 1.14
Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). Clin Infect Dis (2013) 1.12
An in vitro network of intermolecular interactions between viral RNA segments of an avian H5N2 influenza A virus: comparison with a human H3N2 virus. Nucleic Acids Res (2012) 1.10
A functional sequence-specific interaction between influenza A virus genomic RNA segments. Proc Natl Acad Sci U S A (2013) 1.06
Influenza burden in children newborn to eleven months of age in a pediatric emergency department during the peak of an influenza epidemic. Pediatr Infect Dis J (2003) 1.06
Gene expression signature-based screening identifies new broadly effective influenza a antivirals. PLoS One (2010) 1.04
Outbreak of acute hemorrhagic conjunctivitis in French Guiana and West Indies caused by coxsackievirus A24 variant: phylogenetic analysis reveals Asian import. J Med Virol (2005) 1.02
Association of respiratory picornaviruses with acute bronchiolitis in French infants. J Clin Virol (2006) 1.02
Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses. Proc Natl Acad Sci U S A (2013) 1.00
Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. PLoS Pathog (2013) 1.00
PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest (2012) 1.00
Influenza vaccination of healthcare workers in acute-care hospitals: a case-control study of its effect on hospital-acquired influenza among patients. BMC Infect Dis (2012) 0.99
Interaction network linking the human H3N2 influenza A virus genomic RNA segments. Vaccine (2012) 0.98
Influenza A viruses control expression of proviral human p53 isoforms p53β and Delta133p53α. J Virol (2012) 0.98
Dermatological spectrum of hand, foot and mouth disease from classical to generalized exanthema. Pediatr Infect Dis J (2014) 0.96
Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particles. Virology (2011) 0.95
Combinatorial effect of two framework mutations (E119V and I222L) in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivir. Antimicrob Agents Chemother (2011) 0.95
Human parainfluenza virus type 4 infections: a report of 20 cases from 1998 to 2002. J Clin Virol (2005) 0.95
Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France. PLoS One (2011) 0.94
Specific RT-PCR procedure for the detection of human parechovirus type 1 genome in clinical samples. J Virol Methods (2002) 0.94
Detection of rhinovirus and enterovirus in upper respiratory tract samples using a multiplex nested PCR. J Virol Methods (2003) 0.92
Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses. Antiviral Res (2008) 0.92
HSV excretion after bone marrow transplantation: a 4-year survey. J Clin Virol (2004) 0.92
Detection of human metapneumovirus RNA sequences in nasopharyngeal aspirates of young French children with acute bronchiolitis by real-time reverse transcriptase PCR and phylogenetic analysis. J Clin Microbiol (2005) 0.90
Cellular transcriptional profiling in human lung epithelial cells infected by different subtypes of influenza A viruses reveals an overall down-regulation of the host p53 pathway. Virol J (2011) 0.89
Human parechovirus infections, Lyon, France, 2008-10: evidence for severe cases. J Clin Virol (2012) 0.89
Parainfluenza virus type 5 (PIV-5) morphology revealed by cryo-electron microscopy. Virus Res (2009) 0.89
Detection of measles vaccine in the throat of a vaccinated child. Vaccine (2002) 0.89
Influenza burden in febrile infants and young children in a pediatric emergency department. Pediatr Infect Dis J (2007) 0.88
Oseltamivir-resistant influenza A(H1N1) viruses in south of France, 2007/2009. Antiviral Res (2010) 0.88
Impact of influenza A virus neuraminidase mutations on the stability, activity, and sensibility of the neuraminidase to neuraminidase inhibitors. J Clin Virol (2008) 0.88
Identification and characterization of a late AH1N2 human reassortant in France during the 2002-2003 influenza season. Virus Res (2007) 0.88
Influenza vaccine effectiveness among adult patients in a University of Lyon hospital (2004-2009). Vaccine (2011) 0.88
Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase. J Gen Virol (2010) 0.87
New introductions of enterovirus 71 subgenogroup C4 strains, France, 2012. Emerg Infect Dis (2014) 0.84
Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe. J Clin Virol (2013) 0.84
Genetic content of Influenza H3N2 vaccine seeds. PLoS Curr (2010) 0.84
Resistance of herpes simplex virus type 1 to acyclovir: thymidine kinase gene mutagenesis study. Antiviral Res (2006) 0.83
Successful H1N1 influenza vaccination of children receiving chemotherapy for solid tumors. J Pediatr Hematol Oncol (2012) 0.82
Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season. Vaccine (2011) 0.82
Epidemiological and clinical characteristics of patients infected with enterovirus D68, France, July to December 2014. Euro Surveill (2016) 0.82
Novel influenza A(H1N1) 2009 in vitro reassortant viruses with oseltamivir resistance. Antivir Ther (2010) 0.82
Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis. Am J Respir Crit Care Med (2015) 0.82
Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France. PLoS One (2012) 0.82
Epidemiology and burden of rotavirus diarrhea in day care centers in Lyon, France. Eur J Pediatr (2006) 0.81
Five years of hospital based surveillance of influenza-like illness and influenza in a short-stay geriatric unit. BMC Res Notes (2014) 0.81
Blocking human enterovirus 71 replication by targeting viral 2A protease. J Antimicrob Chemother (2012) 0.81
Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits. Cell Mol Life Sci (2013) 0.81
Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005. Vaccine (2006) 0.81
Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections. Antiviral Res (2012) 0.80
Rescue of a H3N2 influenza virus containing a deficient neuraminidase protein by a hemagglutinin with a low receptor-binding affinity. PLoS One (2012) 0.80
Fatal influenza A(H1N1)pdm09 encephalopathy in immunocompetent man. Emerg Infect Dis (2013) 0.79
Impaired glutamate uptake and EAAT2 downregulation in an enterovirus chronically infected human glial cell line. Eur J Neurosci (2003) 0.79
Echovirus 6 strains derived from a clinical isolate show differences in haemagglutination ability and cell entry pathway. Virus Res (2007) 0.79
A screening dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus isolates to acyclovir. J Virol Methods (2002) 0.78
Cytomegalovirus and adenovirus infections and diseases among 75 paediatric unrelated allogeneic bone marrow transplant recipients. J Med Virol (2004) 0.78
H1N1 influenza A virus neuraminidase modulates infectivity in mice. Antiviral Res (2012) 0.78
[EBV-induced fulminant hepatic failure: favorable outcome after liver transplantation]. Gastroenterol Clin Biol (2007) 0.78
Ex vivo and in vivo inhibition of human rhinovirus replication by a new pseudosubstrate of viral 2A protease. J Virol (2011) 0.78
The influenza fingerprints: NS1 and M1 proteins contribute to specific host cell ultrastructure signatures upon infection by different influenza A viruses. Virology (2012) 0.78
RNA extraction and RT-PCR procedures adapted for the detection of enterovirus sequences from frozen and paraffin-embedded formalin-fixed spinal cord samples. J Virol Methods (2003) 0.78
Cumulative mutations in the genome of Echovirus 6 during establishment of a chronic infection in precursors of glial cells. Virus Genes (2005) 0.77
Outbreak of aseptic meningitis in Djibouti in the aftermath of El Niño. Trans R Soc Trop Med Hyg (2004) 0.77
Influenza NS1 interacts with p53 and alters its binding to p53-responsive genes, in a promoter-dependent manner. FEBS Lett (2013) 0.77
The clinical interest of HSV1 semi-quantification in bronchoalveolar lavage. J Clin Virol (2013) 0.77
Measurement of enzymatic activity and specificity of human and avian influenza neuraminidases from whole virus by glycoarray and MALDI-TOF mass spectrometry. Chembiochem (2011) 0.77
Myocarditis and cardiac channelopathies: a deadly association? Int J Cardiol (2011) 0.76
T inflammatory memory CD8 T cells participate to antiviral response and generate secondary memory cells with an advantage in XCL1 production. Immunol Res (2012) 0.76
Effects of mutations on herpes simplex virus 1 thymidine kinase functionality: an in vitro assay based on detection of monophosphate forms of acyclovir and thymidine using HPLC/DAD. Antiviral Res (2012) 0.76
Nutrition- and virus-induced stress represses the expression of manganese superoxide dismutase in vitro. Exp Biol Med (Maywood) (2004) 0.76
Supplemental treatment of air in airborne infection isolation rooms using high-throughput in-room air decontamination units. Am J Infect Control (2010) 0.76
Cerebrospinal fluid detection of enterovirus genome in ALS: a study of 242 patients and 354 controls. Amyotroph Lateral Scler (2010) 0.76
Recent developments with live-attenuated recombinant paramyxovirus vaccines. Rev Med Virol (2012) 0.75
[Antagonists of PAR1: towards a new antiviral strategy against flu]. Med Sci (Paris) (2013) 0.75
Vaginal Neoplasia Induced by an Unusual Papillomavirus Subtype in a Woman with Inherited Chromosomally Integrated Human Herpesvirus Type 6A. Gynecol Obstet Invest (2017) 0.75
Multicenter evaluation of the ENTEROVIRUS R-gene real-time RT-PCR assay for the detection of enteroviruses in clinical specimens. J Clin Virol (2009) 0.75
Characterization of a key residue for hyperfusogenic phenotype in human parainfluenza virus type 2 (hPIV-2) fusion glycoprotein. Virus Genes (2013) 0.75
[Herpes as viewed by the French: result of a survey conducted on 10,000 persons]. Pathol Biol (Paris) (2002) 0.75
[Herpes serology for genital herpes]. Presse Med (2008) 0.75
Rapid diagnosis of acute hemorrhagic conjunctivitis due to coxsackievirus A24 variant by real-time one-step RT-PCR. J Virol Methods (2007) 0.75
Temporal surveillance of the humoral immunity against influenza vaccine in the elderly over 9 consecutive years. Gerontology (2003) 0.75
Divergent genetic evolution of hemagglutinin in influenza A H1N1 and A H1N2 subtypes isolated in the south-France since the winter of 2001-2002. J Clin Virol (2005) 0.75
[Avian influenza causes fear about a pandemic]. Servir (2004) 0.75